Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adoptive cellular therapy: a therapeutic reality?

Karl S Peggs1, Stephen Mackinnon

  • 1Department of Haematology, University College Hospital, London, UK. kpeggs@hotmail.com

Hematology (Amsterdam, Netherlands)
|September 24, 2002
PubMed
Summary

Cellular immunotherapy shows promise for treating human malignancies, but clinical application faces challenges. Research focuses on identifying specific targets to improve anti-tumor activity and immunological recovery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autologous and allogeneic haematopoietic cell transplantation in adult patients with Hodgkin lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee and Lymphoma Working Party.

The Lancet. Haematology·2026
Same author

A comparison of two manufacturing methods in the phase I COBALT study of CD19CAR T for LBCL.

Molecular therapy. Advances·2026
Same author

Regulatory T Cell Depletion in Cancer: Challenges, Opportunities, and Future Directions for Antibody Development.

Annual review of medicine·2025
Same author

Matched donor allogeneic CAR-T for adult B-ALL: toxicity, efficacy, repeat dosing, and the importance of lymphodepletion.

Blood·2025
Same author

Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies.

Immunity·2025
Same author

Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies.

Immunity·2025

Area of Science:

  • Oncology
  • Immunology
  • Cancer Therapy

Background:

  • Emerging evidence suggests human malignancies are sensitive to cellular immunotherapy.
  • Understanding effector cells and target antigens is crucial for therapeutic development.

Purpose of the Study:

  • To review advancements in cellular immunotherapy for cancer.
  • To highlight challenges and future directions in harnessing immune responses against tumors.

Main Methods:

  • Review of recent scientific literature on cellular immunotherapy and cancer.
  • Analysis of progress in allogeneic stem cell transplantation for anti-tumor effects.
  • Discussion of tumor-specific and tumor-selective target identification.

Main Results:

  • Clinical application of cellular immunotherapy is more complex than initially expected.
  • Allogeneic stem cell transplantation offers strategies to enhance anti-tumor activity and immune recovery.
  • Identification of allospecific targets is promising, with ongoing efforts to find tumor-specific targets.

Conclusions:

  • Cellular immunotherapy holds significant potential for treating cancer.
  • Further research is needed to overcome clinical challenges and refine therapeutic strategies.
  • Developing effective tumor-specific or tumor-selective targets is key for broader application.

Related Experiment Videos